Online First

December 11, 2019

Correspondence response
Response to: ‘Correspondence to ‘Slope sign’: a feature of large vessel vasculitis?’ by Milchert et al
Free

Alwin Sebastian, Abdul Kayani, Bhaskar Dasgupta

doi: 10.1136/annrheumdis-2019-216690

December 09, 2019

Correspondence
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease
Free

Corrado Campochiaro, Giulio Cavalli, Nicola Farina, Alessandro Tomelleri, Giacomo De Luca, Lorenzo Dagna

doi: 10.1136/annrheumdis-2019-216610
Correspondence response
Response to: ‘Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al’ by Berkhout et al
Free

Yoshiya Tanaka, Koji Oba, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2019-216593
Correspondence response
Response to: ‘NCF1-339 polymorphism and systemic lupus erythematosus’ by Joob and Wiwanitkit
Free

Carl Petrus Linge, Anders Bengtsson

doi: 10.1136/annrheumdis-2019-216669

December 06, 2019

Correspondence
Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus
Free

Bin Wang, Shiju Chen, Qing Zheng, Zhenyu Gao, Rongjuan Chen, Jingxiu Xuan, Yuan Liu, Guixiu Shi

doi: 10.1136/annrheumdis-2019-216695
Correspondence
New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion
Free

Karim Sacre, Laure Delaval, Antoine Dossier, Jean-Francois Alexandra, Marie Berleur, Marie-Paule Chauveheid, Gregory Ducrocq, Tiphaine Goulenok, Damien van Gysel, Diane Rouzaud, Thomas Papo

doi: 10.1136/annrheumdis-2019-216712

December 04, 2019

Correspondence response
Response to: ‘Association between osteoporosis and statin therapy: the story continues’ by Burden and Weiler
Free

Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek, Alexandra Kautzky-Willer

doi: 10.1136/annrheumdis-2019-216627
Correspondence response
Naproxen or low-dose colchicine for gout flares in primary care? Response to: ‘Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care’ by Parperis et al
Free

Edward Roddy, Christian D Mallen on behalf of the CONTACT trial authors

doi: 10.1136/annrheumdis-2019-216671
Correspondence response
Response to: ‘Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients’ by Ogawa-Momohara et al
Free

Lionel Spielmann, Benoit Nespola, Alain Meyer

doi: 10.1136/annrheumdis-2019-216413

December 02, 2019

Correspondence
Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares
Free

Arnaud M Didierlaurent, Christophe Desssart, Anthony L Cunningham

doi: 10.1136/annrheumdis-2019-216639

November 28, 2019

Correspondence
NCF1-339 polymorphism and systemic lupus erythematosus
Free

Beuy Joob, Viroj Wiwanitkit

doi: 10.1136/annrheumdis-2019-216629
Correspondence response
Intestinal dysbiosis in RA development: difficulty of establishing causality. Response to: ‘Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study’ by Inamo
Free

Deshire Alpizar Rodriguez, Till Robin Lesker, Benoît Gilbert, Till Strowig, Axel Finckh

doi: 10.1136/annrheumdis-2019-216637

November 27, 2019

Correspondence
Correspondence to ‘Slope sign’: a feature of large vessel vasculitis?
Free

Marcin Milchert, Marek Brzosko, Anne Bull Haaversen, Andreas P Diamantopoulos

doi: 10.1136/annrheumdis-2019-216601
Correspondence
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care
Free

Konstantinos Parperis

doi: 10.1136/annrheumdis-2019-216643

November 22, 2019

Correspondence
Involvement of industry in review articles published in Annals of the Rheumatic Diseases
Free

Martin Rudwaleit

doi: 10.1136/annrheumdis-2019-216544
Correspondence
European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist’s point of view
Free

Maria Infantino, Mariangela Manfredi, Nicola Bizzaro On behalf of the Study Group on Autoimmune Diseases of the Italian Society of Clinical Pathology and Laboratory Medicine

doi: 10.1136/annrheumdis-2019-216591

November 20, 2019

Correspondence
Anti-Ku antibodies: important points to consider
Free

Michael Mahler, Minoru Satoh, Marvin J Fritzler

doi: 10.1136/annrheumdis-2019-216535
Correspondence response
Response to: ‘Anti-Ku antibodies: important points to consider’ by Mahler et al
Free

Mariko Ogawa-Momohara, Yoshinao Muro, Masashi Akiyama

doi: 10.1136/annrheumdis-2019-216595

November 19, 2019

Correspondence
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors
Free

Anja Meyer, Paula S Wittekind, Konstantin Kotschenreuther, Joanna Schiller, Julia von Tresckow, Thomas H Haak, David M Kofler

doi: 10.1136/annrheumdis-2019-216576
Correspondence
Association between osteoporosis and statins therapy: the story continues
Free

Andrea Michelle Burden, Stefan Weiler

doi: 10.1136/annrheumdis-2019-216574
Correspondence
Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al
Free

Lea C Berkhout, Merel J l'Ami, Gerrit Jan Wolbink, Theo Rispens

doi: 10.1136/annrheumdis-2019-216557
Correspondence
Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study
Free

Jun Inamo

doi: 10.1136/annrheumdis-2019-216565

November 15, 2019

Correspondence
The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus
Free

Sheng-Xiao Zhang, Jia Wang, Jun-Wei Chen, Ming-Xing Zhang, Yi-Fan Zhang, Fang-Yuan Hu, Zhi-Qin Lv, Chong Gao, Ya-Feng Li, Xiao-Feng Li

doi: 10.1136/annrheumdis-2019-216504
Correspondence response
Response to: ‘The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus’ by Zhang et al and the phylogeny of a candidate pathobiont in lupus nephritis
Free

Gregg J Silverman, Doua F Azzouz

doi: 10.1136/annrheumdis-2019-216523

November 14, 2019

Correspondence
Gut microbiome in rheumatic diseases
Free

Sergey Moiseev, Vilen Rameev, Ekaterina Karovaikina, Lidia Lysenko (Kozlovskaya)

doi: 10.1136/annrheumdis-2019-216560

November 05, 2019

Correspondence
Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?
Free

Gerasimos Evangelatos, George E Fragoulis, Alexios Iliopoulos

doi: 10.1136/annrheumdis-2019-216527

October 25, 2019

Correspondence
Association between osteoporosis and statins therapy
Free

Shih-Wei Lai

doi: 10.1136/annrheumdis-2019-216464
Correspondence response
Adapting the MS score for detection of macrophage activation syndrome in adult-onset Still’s disease. Response to ‘Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease’ by Wang et al
Free

Francesca Minoia, Angelo Ravelli

doi: 10.1136/annrheumdis-2019-216310
Correspondence response
Response to: ‘The association between osteoporosis and statins therapy’ by Lai
Free

Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek, Alexandra Kautzky-Willer

doi: 10.1136/annrheumdis-2019-216494

October 18, 2019

Correspondence
Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease
Free

Ran Wang, Ting Li, Shuang Ye, Wenefng Tan, Cheng Zhao, Yisha Li, Chunde Bao, Qiong Fu

doi: 10.1136/annrheumdis-2019-216286
Correspondence response
On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: ‘On using machine learning algorithms to define clinical meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Free

Alain Meyer, Lionel Spielmann, François Séverac

doi: 10.1136/annrheumdis-2019-215868
Correspondence
Role of ANA testing in the classification of patients with systemic lupus erythematosus
Free

David S Pisetsky, Diane M Spencer, Brad Rovin, Peter E Lipsky

doi: 10.1136/annrheumdis-2019-216259
Correspondence
Gut-derived CD8⁺ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients
Free

Giuliana Guggino, Aroldo Rizzo, Daniele Mauro, Federica Macaluso, Francesco Ciccia

doi: 10.1136/annrheumdis-2019-216456

October 15, 2019

Correspondence response
Response to: ‘Diabetes mellitus in ankylosing spondylitis’ by Lee and Song
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216429
Correspondence response
Possible adaptations of vascularised human skin equivalents to include rare cell populations and study fibroblast heterogeneity. Response to: ‘In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes?’ by Manetti and Matucci-Cerinic
Free

Alexandru Emil Matei, Jörg H W Distler

doi: 10.1136/annrheumdis-2019-216393
Correspondence response
Response to: ‘Comment on: standardisation of myositis-specific antibodies: where are we today?’ by Infantino et al
Free

Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg

doi: 10.1136/annrheumdis-2019-216248
Correspondence
Diabetes mellitus in ankylosing spondylitis
Free

Young Ho Lee, Gwan Gyu Song

doi: 10.1136/annrheumdis-2019-216335

October 14, 2019

Correspondence
Titre-specific positive predictive value of antinuclear antibody patterns
Free

Jean-Baptiste Vulsteke, Lieve Van Hoovels, Philippe Willems, Bert Vander Cruyssen, Steven Vanderschueren, Rene Westhovens, Daniel Blockmans, Ellen De Langhe, Xavier Bossuyt

doi: 10.1136/annrheumdis-2019-216245
Correspondence
Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
Free

Sheng-Xiao Zhang, Jia Wang, He-Hua Sun, Jia-Qian Zhang, Guang-Ying Liu, Jing Luo, Pei-Feng He, Xiao-Feng Li

doi: 10.1136/annrheumdis-2019-216246
Correspondence
Incidence of inflammatory bowel disease in patients with ankylosing spondylitis
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216362
Correspondence
Bone health in patients with systemic lupus erythematosus
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216417
Correspondence response
On the therapeutic scope of low-dose IL-2. Response to: ‘Circulating regulatory T cells were absolutelydecreased in dermatomyositis/polymyositispatients and restored by low-dose IL-2’ by Zhang et al
Free

David Klatzmann

doi: 10.1136/annrheumdis-2019-216267

October 11, 2019

Correspondence
Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients
Free

Mariko Ogawa-Momohara, Yoshinao Muro, Masashi Akiyama

doi: 10.1136/annrheumdis-2019-216375
Correspondence response
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al’ by Agca et al
Free

Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone

doi: 10.1136/annrheumdis-2019-216407

Main menu

Online First

December 20, 2019

December 18, 2019

December 13, 2019

December 12, 2019

December 11, 2019

December 09, 2019

December 06, 2019

December 04, 2019

December 02, 2019

November 28, 2019

November 27, 2019

November 22, 2019

November 20, 2019

November 19, 2019

November 15, 2019

November 14, 2019

November 05, 2019

October 25, 2019

October 18, 2019

October 15, 2019

October 14, 2019

October 11, 2019

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

December 20, 2019

December 18, 2019

December 13, 2019

December 12, 2019

December 11, 2019

December 09, 2019

December 06, 2019

December 04, 2019

December 02, 2019

November 28, 2019

November 27, 2019

November 22, 2019

November 20, 2019

November 19, 2019

November 15, 2019

November 14, 2019

November 05, 2019

October 25, 2019

October 18, 2019

October 15, 2019

October 14, 2019

October 11, 2019

Pages